Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Azenta, Inc. (NASDAQ:AZTA). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Azenta stock on January 15th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Banco Santander (NYSE:SAN) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Leonardo (OTCMKTS:FINMF) on 2/3/2026.
- Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 1/30/2026.
- Purchased $1,001 – $15,000 in shares of Transdigm Group (NYSE:TDG) on 1/30/2026.
- Purchased $1,001 – $15,000 in shares of Cloudflare (NYSE:NET) on 1/30/2026.
- Purchased $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 1/30/2026.
Azenta Stock Performance
Shares of NASDAQ AZTA opened at $29.28 on Friday. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $47.55. The firm’s 50 day moving average price is $34.92 and its 200 day moving average price is $32.58. The firm has a market cap of $1.35 billion, a P/E ratio of -21.69 and a beta of 1.35.
Azenta declared that its board has authorized a share repurchase plan on Wednesday, December 10th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to reacquire up to 14.9% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.
Institutional Trading of Azenta
Several institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Azenta by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 4,538,946 shares of the company’s stock valued at $150,965,000 after purchasing an additional 99,588 shares during the last quarter. Millennium Management LLC increased its stake in shares of Azenta by 9.9% in the fourth quarter. Millennium Management LLC now owns 1,866,531 shares of the company’s stock valued at $62,081,000 after purchasing an additional 167,969 shares during the period. State Street Corp increased its stake in shares of Azenta by 1.4% in the fourth quarter. State Street Corp now owns 1,732,755 shares of the company’s stock valued at $57,631,000 after purchasing an additional 24,062 shares during the period. GW&K Investment Management LLC raised its holdings in shares of Azenta by 37.1% during the fourth quarter. GW&K Investment Management LLC now owns 1,550,101 shares of the company’s stock valued at $51,556,000 after buying an additional 419,630 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Azenta by 7.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,388,047 shares of the company’s stock worth $46,347,000 after buying an additional 99,897 shares during the period. Institutional investors own 99.08% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have issued reports on AZTA. Needham & Company LLC restated a “buy” rating and set a $44.00 price objective on shares of Azenta in a report on Wednesday, February 4th. TD Cowen restated a “hold” rating on shares of Azenta in a research note on Wednesday, February 4th. Wall Street Zen cut shares of Azenta from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Evercore decreased their price objective on shares of Azenta from $50.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, February 5th. Finally, Jefferies Financial Group dropped their target price on shares of Azenta from $42.00 to $40.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Four equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $41.33.
Read Our Latest Stock Report on Azenta
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About Azenta
Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Featured Stories
- Five stocks we like better than Azenta
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
